在患有EEF1A2相关的儿科患者中,现象和对抗药物的反应
Hee-Jeong Yun1, Soo Yeon Kim2, Woojoong Kim3
1Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea.
Brain & development
|June 20, 2025
概括
与EEF1A2相关的具有广泛的症状,从严重的早期发病情况到较轻的形式. 广谱抗发作药物 (ASM) 在大多数儿科患者中有效控制了发作.
科学领域:
- 遗传学和神经学 遗传学和神经学
- 儿科综合征 儿科综合征
背景情况:
- 与EEF1A2突变相关的具有复杂的临床谱.
- 了解表型和治疗反应对于管理儿科患者至关重要.
研究的目的:
- 在EEF1A2相关的中划分现型的谱.
- 评估抗发作药物 (ASM) 在患有EEF1A2突变的儿科患者的疗效.
主要方法:
- 76名患有EEF1A2突变的儿科患者 (7个机构,69个文献) 的回顾性分析.
- 收集的数据包括发作发作,类型,综合征,ASM反应和神经发育结果.
- 根据国际抗联盟指南分类的综合征.
主要成果:
- 在80%的患者中存在,平均发病时间为4.5个月; 56%的患者在12个月前开始.
- 一般性发作占主导地位 (67%),包括性.
- 发育性脑病变 (DEE) 发生在59%的患者中,也发现了较轻微的表型.
- 在65%的患者中,广泛的ASM (瓦尔酸,拉莫特里金,勒维他拉cetam) 控制了发作.
- 特定突变 (p.Gly70Ser,p.Glu122Lys) 与严重的DEE相关.
结论:
- 与EEF1A2相关的表现出广泛的表型谱,从严重的早期发作到较温和的形式.
- 某些EEF1A2突变与严重发育性脑病变 (DEE) 有关.
- 在大多数患者中,使用广谱ASM可以实现有效的控制.
关键词:
抗发作药物 抗发作药物发育性性脑病变是一种发育性性脑病变.EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1A2EEF1E1E1E1E1E2E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1E1的表型 的表型基因型-表型相关性相关性儿科 - 儿科更多相关视频
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.5K
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.2K
相关概念视频
01:24Epilepsy and Seizures: Overview
296
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
01:20Antiepileptic Drugs: Potassium Channel Activators
289
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
289
01:13Seizures: Classification
612
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
612
01:08Antiepileptic Drugs: Sodium Channel Blockers
950
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
950
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
461
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
461
01:14Antiepileptic Drugs: Glutamate Antagonists
527
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
527